These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

557 related items for PubMed ID: 30429236

  • 1. LncRNA GAS8-AS1 suppresses papillary thyroid carcinoma cell growth through the miR-135b-5p/CCND2 axis.
    Chen N, Yin D, Lun B, Guo X.
    Biosci Rep; 2019 Jan 31; 39(1):. PubMed ID: 30429236
    [Abstract] [Full Text] [Related]

  • 2. Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p.
    Wang D, Zheng Y.
    Endocr J; 2021 May 28; 68(5):583-597. PubMed ID: 33612561
    [Abstract] [Full Text] [Related]

  • 3. LncRNA TNRC6C-AS1 regulates UNC5B in thyroid cancer to influence cell proliferation, migration, and invasion as a competing endogenous RNA of miR-129-5p.
    Hou S, Lin Q, Guan F, Lin C.
    J Cell Biochem; 2018 Nov 28; 119(10):8304-8316. PubMed ID: 29893424
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. NR2F1-AS1 regulated miR-423-5p/SOX12 to promote proliferation and invasion of papillary thyroid carcinoma.
    Yang C, Liu Z, Chang X, Xu W, Gong J, Chai F, Cui D.
    J Cell Biochem; 2020 Feb 28; 121(2):2009-2018. PubMed ID: 31692033
    [Abstract] [Full Text] [Related]

  • 6. Long non-coding RNA ASMTL-AS1 inhibits tumor growth and glycolysis by regulating the miR-93-3p/miR-660/FOXO1 axis in papillary thyroid carcinoma.
    Feng Z, Chen R, Huang N, Luo C.
    Life Sci; 2020 Mar 01; 244():117298. PubMed ID: 31953163
    [Abstract] [Full Text] [Related]

  • 7. CERS6-AS1 Facilitates Oncogenesis and Restrains Ferroptosis in Papillary Thyroid Carcinoma by Serving as a ceRNA through miR-497-5p/LASP1 Axis.
    Huang T, Guan S, Wang C.
    Ann Clin Lab Sci; 2022 May 01; 52(3):426-438. PubMed ID: 35777805
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Long noncoding RNA ABHD11-AS1 functions as a competing endogenous RNA to regulate papillary thyroid cancer progression by miR-199a-5p/SLC1A5 axis.
    Zhuang X, Tong H, Ding Y, Wu L, Cai J, Si Y, Zhang H, Shen M.
    Cell Death Dis; 2019 Aug 14; 10(8):620. PubMed ID: 31409775
    [Abstract] [Full Text] [Related]

  • 13. Long non-coding RNA LIFR-AS1 suppressed the proliferation, angiogenesis, migration and invasion of papillary thyroid cancer cells via the miR-31-5p/SIDT2 axis.
    Yi D, Zhang D, He J.
    Cell Cycle; 2021 Dec 14; 20(24):2619-2637. PubMed ID: 34781815
    [Abstract] [Full Text] [Related]

  • 14. LncRNA CALML3-AS1 suppresses papillary thyroid cancer progression via sponging miR-20a-5p/RBM38 axis.
    Zhang X, Zhang X, Jia Q, Li H, Ma R, Yang G, Yin F, Jiang N, Yin D.
    BMC Cancer; 2022 Mar 29; 22(1):344. PubMed ID: 35351042
    [Abstract] [Full Text] [Related]

  • 15. STAT3-induced upregulation of lncRNA ABHD11-AS1 promotes tumour progression in papillary thyroid carcinoma by regulating miR-1301-3p/STAT3 axis and PI3K/AKT signalling pathway.
    Wen J, Wang H, Dong T, Gan P, Fang H, Wu S, Li J, Zhang Y, Du R, Zhu Q.
    Cell Prolif; 2019 Mar 29; 52(2):e12569. PubMed ID: 30657221
    [Abstract] [Full Text] [Related]

  • 16. Long noncoding RNA FOXD2-AS1 promotes glioma malignancy and tumorigenesis via targeting miR-185-5p/CCND2 axis.
    Shen F, Chang H, Gao G, Zhang B, Li X, Jin B.
    J Cell Biochem; 2019 Jun 29; 120(6):9324-9336. PubMed ID: 30520141
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of LncRNA FOXD3-AS1 suppresses the aggressive biological behaviors of thyroid cancer via elevating miR-296-5p and inactivating TGF-β1/Smads signaling pathway.
    Chen Y, Gao H, Li Y.
    Mol Cell Endocrinol; 2020 Jan 15; 500():110634. PubMed ID: 31678422
    [Abstract] [Full Text] [Related]

  • 18. A novel lncRNA n384546 promotes thyroid papillary cancer progression and metastasis by acting as a competing endogenous RNA of miR-145-5p to regulate AKT3.
    Feng J, Zhou Q, Yi H, Ma S, Li D, Xu Y, Wang J, Yin S.
    Cell Death Dis; 2019 Jun 03; 10(6):433. PubMed ID: 31160577
    [Abstract] [Full Text] [Related]

  • 19. Silencing of long noncoding RNA RP11-476D10.1 enhances apoptosis and autophagy while inhibiting proliferation of papillary thyroid carcinoma cells via microRNA-138-5p-dependent inhibition of LRRK2.
    Zhao Y, Zhao L, Li J, Zhong L.
    J Cell Physiol; 2019 Nov 03; 234(11):20980-20991. PubMed ID: 31102261
    [Abstract] [Full Text] [Related]

  • 20. LncRNA MCM3AP-AS1 promotes proliferation and invasion through regulating miR-211-5p/SPARC axis in papillary thyroid cancer.
    Liang M, Jia J, Chen L, Wei B, Guan Q, Ding Z, Yu J, Pang R, He G.
    Endocrine; 2019 Aug 03; 65(2):318-326. PubMed ID: 31030335
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.